ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0220

Ultrasound-assessed Dactylitis as a Biomarker in the Early Diagnosis of Psoriatic Arthritis

Otto Olivas-Vergara1, Raquel Largo2, Lina Martínez-Estupiñán3, Fredeswinda Romero-Bueno4, Olga Sánchez-Pernaute3, Javier R. Godo3, Maria del Carmen Fariña-Sabaris5, Belen Ruffin Vicente5, Carmen Herencia6, Aránzazu Mediero2, Agustina Criado Alcazar7, Pablo E. Borges1, Sheila Recuero-Díaz1, Andrea Alvear-Torres3, Amalia Gil3, Antía García-Fernández3, Ana Elena Hoyo Fernandez8, M. Isabel Sanchez-Barba8, M. Belen Ortega Trompeta8, Cristina Vazquez-Carballo9, Gabriel Herrero-Beaumont3 and ESPERANZA NAREDO10, 1Department of Rheumatology and Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz and IIS-FJD, Madrid, Spain, 2Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz, Madrid, Spain, 3Department of Rheumatology and Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz and IIS-FJD. Autonomous University of Madrid, Madrid, Spain, 4Hospital Universitario Fundación Jiménez Díaz and IIS-FJD. Autonomous University of Madrid, Madrid, Spain, 5Department of Dermatology.Hospital Universitario Fundación Jiménez Díaz and IIS-FJD. Autonomous University of Madrid, Madrid, Spain, 6Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz, M, Spain, 7Primary Care..Centro de Salud Paseo Imperial, Madrid, Spain, 8Primary Care.Centro de Salud Paseo Imperial, Madrid, Spain, 9Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz. Autonomous University of Madrid, Madrid, Spain, 10Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

Meeting: ACR Convergence 2024

Keywords: Arthroplasty, Imaging, Psoriatic arthritis, Synovitis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Imaging of Rheumatic Diseases Poster I: Inflammatory Arthritis

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The primary objective of this prospective, longitudinal, observational study was to evaluate the predictive value of ultrasound (US)-detected elementary lesions of dactylitis together with US-assessed inflammation in other peripheral sites in relation to PsA diagnosis in psoriatic (PsO) patients with finger arthralgia. In addition, we investigated the relation between serum levels of different proinflammatory cytokines and PsA diagnosis in this population

Methods: We included adult patients diagnosed with PsO with or without other musculoskeletal complaints. Exclusion criteria were the presence of PsA or any other inflammatory arthropathy at inclusion and treatment with DMARD in the previous 6 months. Patients were recruited by local dermatologists, general practitioners, or rheumatologists. Patients were clinically assessed at baseline, 6 and 12 months by an expert rheumatologist blinded to the US findings. At baseline, patients underwent a B-mode (BM) and power Doppler mode (DM) US assessment by the same rheumatologist, highly expert in this technique and blinded to clinical data. The US evaluation included bilateral detection and scoring of synovitis (3 joints, 0-3), tenosynovitis (flexor tendons, 0-3), enthesitis (9 sites, 0-1), peri-extensor tendoninflammation (PETI)(0-3), and subcutaneous tissue inflammation(SCTI) (0-3) in 2nd-5th fingers. In addition, synovitis, tenosynovitis and enthesitis were detected and scored (0-3) bilaterally at 4 extradigital sites each. Global indices of digital and extra-digital lesions were obtained from the sum of the scores of the corresponding sites. Serum levels of proinflammatory cytokines were measured at baseline employing a cytokine antibody array. The primary outcome was to diagnose PsA judged by an expert rheumatologist during the 12-month follow-up

Results: 70 patients [44 women; mean (SD) age 51 (12.4) years]were included, of whom 64 completed the study.Of these, 15 (23.4%) were diagnosed with PsA during the 12-month follow-up period. At finger level, the presence of baseline BM synovitis (χ2=8.04; p=0.006), DM synovitis (χ2=13.55; p=0.001), BM tenosynovitis (χ2=21.13; p=0.001), BM enthesitis (χ2=30.36; p< 0.001), DM enthesitis (χ2=29.87; p< 0.001), BM PETI(χ2=17.72; p< 0.001), and DM PETI(χ2=10.28; p=0.011) were associated with PsA diagnosis.Table 1 and Table 2 show the comparison of baseline global indices of digital and extra-digital lesions, respectively, between patients who were and were not diagnosed with PsA. At finger level, global BM synovitis, DM synovitis, BM tenosynovitis, DM tenosynovitis, BM enthesitis, DM enthesitis, BM PETI, and DM PETI were significantly higher in patients diagnosed with PsA(p< 0.05).In multivariate analysis of digital and extra-digital US variables, a final model including 4 US variables was predictive of PsA diagnosis (χ2=44.75; p< 0.001) with a sensitivity of 80.0% and a specificity of 89.8% (Table 3).Regarding serum concentration of cytokines, only IL-22 and IL-17F were significantly different between groups

Conclusion: US-detected lesions of dactylitis together with extra-digital inflammation predict the diagnosis of PsA in PsO patients with finger arthralgia

Supporting image 1

Comparison of global indices of digital lesions between patients who were and were not diagnosed withPsA. The results of the Mann-Whitney U test for comparison of medians are presented; means and SD are also shown

Supporting image 2

Comparison of global indices of extra-digital lesions between patients who were and were not diagnosed withPsA. The results of the Mann-Whitney U test for comparison of medians are presented; means and SD are also shown

Supporting image 3

Multivariate regression analysis for US variables associated with PsA diagnosis


Disclosures: O. Olivas-Vergara: UCB, 6; R. Largo: None; L. Martínez-Estupiñán: AbbVie/Abbott, 3; F. Romero-Bueno: None; O. Sánchez-Pernaute: None; J. Godo: None; M. Fariña-Sabaris: AbbVie/Abbott, 6, Janssen, 6, Novartis, 6, UCB, 6; B. Ruffin Vicente: None; C. Herencia: None; A. Mediero: None; A. Criado Alcazar: None; P. Borges: None; S. Recuero-Díaz: None; A. Alvear-Torres: None; A. Gil: None; A. García-Fernández: None; A. Hoyo Fernandez: None; M. Sanchez-Barba: None; M. Ortega Trompeta: None; C. Vazquez-Carballo: None; G. Herrero-Beaumont: None; E. NAREDO: Eli Lilly, 5, Novartis, 6.

To cite this abstract in AMA style:

Olivas-Vergara O, Largo R, Martínez-Estupiñán L, Romero-Bueno F, Sánchez-Pernaute O, Godo J, Fariña-Sabaris M, Ruffin Vicente B, Herencia C, Mediero A, Criado Alcazar A, Borges P, Recuero-Díaz S, Alvear-Torres A, Gil A, García-Fernández A, Hoyo Fernandez A, Sanchez-Barba M, Ortega Trompeta M, Vazquez-Carballo C, Herrero-Beaumont G, NAREDO E. Ultrasound-assessed Dactylitis as a Biomarker in the Early Diagnosis of Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/ultrasound-assessed-dactylitis-as-a-biomarker-in-the-early-diagnosis-of-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-assessed-dactylitis-as-a-biomarker-in-the-early-diagnosis-of-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology